Does AMIKACIN Cause Product dose omission issue? 677 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 677 reports of Product dose omission issue have been filed in association with AMIKACIN (ARIKAYCE). This represents 6.0% of all adverse event reports for AMIKACIN.
677
Reports of Product dose omission issue with AMIKACIN
6.0%
of all AMIKACIN reports
105
Deaths
442
Hospitalizations
How Dangerous Is Product dose omission issue From AMIKACIN?
Of the 677 reports, 105 (15.5%) resulted in death, 442 (65.3%) required hospitalization, and 3 (0.4%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMIKACIN. However, 677 reports have been filed with the FAERS database.
What Other Side Effects Does AMIKACIN Cause?
Cough (1,472)
Off label use (1,447)
Dyspnoea (1,367)
Hospitalisation (1,325)
Therapy interrupted (1,283)
Drug ineffective (1,275)
Death (1,005)
Dysphonia (914)
Fatigue (602)
Nausea (562)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which AMIKACIN Alternatives Have Lower Product dose omission issue Risk?
AMIKACIN vs AMILORIDE
AMIKACIN vs AMILORIDE\HYDROCHLOROTHIAZIDE
AMIKACIN vs AMINO ACIDS
AMIKACIN vs AMINO ACIDS, SOURCE UNSPECIFIED
AMIKACIN vs AMINO ACIDS\ANHYDROUS DEXTROSE\CALCIUM\MAGNESIUM HEPTAHYDRATE\POTASSIUM\SODIUM\SODIUM GLYCEROPHOSPHATE ANHYDROUS\SOYBEAN OIL